Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
3100 results found
2025 ∙ Chandeying, N. Khantee, P. Puetpaiboon, S. Thongseiratch, T.
Gender-neutral vs. gender-specific strategies in school-based HPV vaccination programs: a systematic review and meta-analysis
Adolescents Adults Human papillomavirus (HPV) Coverage Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Xu, Q. Zhao, T. Cai, X. Wang, M. Ao, L. Wei, T. Yang, H. Zhang, S. Zhang, X. Jin, S. Wang, X. Feng, X. Zhao, J. Wu, Y. Yang, J. Cui, F.
Global Hesitancy of COVID-19 Vaccine Among Vulnerable Population From 2020 to 2023: A Systematic Review and Meta-Analysis
Adults Older adults COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Han, J. Zhang, L. Chen, Y. Zhang, Y. Wang, L. Cai, R. Li, M. Dai, Y. Dang, L. Chen, H. Zhu, L.
Global HPV vaccination programs and coverage rates: a systematic review
Adolescents Adults Human papillomavirus (HPV) Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Zhao, T. Xu, Q. Cai, X. Wang, M. Ao, L. Wei, T. Yang, H. Zhang, S. Zhang, X. Jin, S. Wang, X. Feng, X. Zhao, J. Wu, Y. Yang, J. Cui, F.
Global spatio-temporal distribution of coronavirus disease 2019 vaccine hesitancy between 2020 and 2022: A meta-analysis
Adults Older adults COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Magalhaes, B. A. P. Medeiros Minasi, J. Lobato, R. C. Lemos, L. C. de Britto, L. S. Barros, R. M. de Martinez, A. M. B. da Hora, V. P.
Globally approved vaccines for COVID-19: a systematic review
Adolescents Adults Older adults COVID-19 Safety Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Zhang, C. Zhang, Y. Q. Liu, R. B. Ma, Y. T. Zhao, L. K. Yin, F. Q. Tu, J. Yao, Y. Y.
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies
Adolescents Adults Older adults COVID-19 Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Maness, S. B. Carpenter, L. C. Akpan, I. St. James, N. Romero-Cely, D. Harmon, G. J. C. Cano, M. Thompson, E. L.
Health Equity and Human Papillomavirus Vaccine Interventions for Adolescents: A Systematic Review
Americas United States of America Adolescents Human papillomavirus (HPV) Coverage Ethical issues
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Githaiga, J. N. Olivier, J. Noll, S. Amponsah-Dacosta, E.
Health System Determinants of Delivery and Uptake of HPV Vaccination Services Among Involuntary Migrant Populations: A Qualitative Systematic Review
All age groups Human papillomavirus (HPV) Coverage Ethical issues Logistics
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Akther, A. Laurie, C. Elton-Marshall, T. Ly, V. Sulis, G.
Healthcare workers' current practices, knowledge/awareness, barriers, and attitudes/perceptions related to pneumococcal vaccination of older adults: A mixed-methods systematic review
All age groups Healthcare workers Pneumococcal disease Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Nembot Fogang, B. A. Debrah, L. B. Owusu, M. Agyei, G. Meyer, J. Gmanyami, J. M. Ritter, M. Arndts, K. Adu Mensah, D. Adjobimey, T. Horauf, A. Debrah, A. Y.
Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
Children Adolescents Adults Pregnant women Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...